Consent for a Phase II diabetes drug trial
Research teams and clinics generate IRB-style, plain-language consent drafts that participants can genuinely understand.
Zobacz podgląd danych wejściowych i wyjściowych
Dane wejściowe
- Procedure Info
- Phase II randomized controlled trial of a new oral diabetes medication (Drug X 500mg) vs. placebo over 12 weeks, including blood draws every 2 weeks and one MRI scan. Participants are adults with Type 2 diabetes. Compensation provided for travel.
- Procedure Type
- clinical-trial
- Risk Level
- moderate
- Audience
- research-participant
- Language Level
- plain-language
Wynik (fragment)
Consent to Take Part in a Research Study What is this study? We are testing a new diabetes pill (Drug X) to see how well it lowers blood sugar. You will be randomly placed in either the Drug X group or a placebo (no medicine) group. Neither you nor the doctor chooses which. What will happen? Over 12 weeks you will have blood drawn every 2 weeks and one MRI scan. Possible risks: Low blood sugar, mild bruising from blood draws. Your participation is voluntary and you may stop at any time.